Blue Note Therapeutics Product BNT 103 Usability and User Engagement
Completed · Not applicable
Conditions studied: Breast Cancer Female
In brief
This test aims to explore product development-focused usability and user engagement.
Key facts
- Study ID
- NCT05032404
- Run by
- Blue Note Therapeutics
- People needed
- 15
- Starts
- 2021-09-01
- Expected to finish
- 2021-12-31
- Last updated by the study team
- 2022-10-19
Who can join
Age: 35 and older, up to 55. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patient can read, write, and speak in English
- Patient is between the ages of 35-55
- Diagnosed with Stage I-III breast cancer
- In active treatment or within 3 months of ending active treatment and under the care of a clinician at time of study
- Apple mobile phone or tablet user
- Willing to participate in study protocol
You may not qualify if…
- Any participant not meeting inclusion criteria
Where it is running
- Blue Note Therapeutics — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.